Limited information indicates that maternal doses of oral diazoxide up to 175 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants. If oral diazoxide is required by the mother, it is not a reason to discontinue breastfeeding. Monitoring of the infant’s blood glucose may be advisable, especially during the newborn period.
有限的信息表明，母亲每日口服高达175毫克的二氮嗪后，乳汁中的含量较低，预计不会对母乳喂养的婴儿造成任何不良影响。如果母亲需要使用口服二氮嗪，这不是停止母乳喂养的理由。建议监测婴儿的血糖，尤其是在新生儿期。
